24/7 Patient Assistance: 760-405-8205

Saeed Sadeghi, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Saeed Sadeghi is known for being an experienced medical oncologist in Santa Monica, California. At Saint Louis University School of Medicine, he obtained his medical degree and did his residency at University of Southern California - LAC+USC Medical Center. Dr. Sadeghi is certified by the American Board in internal medicine, medical oncology and hematology. He has between 11 – 20 years of experience and is currently affiliated with Ronald Reagan UCLA Medical Center and UCLA Medical Center, Santa Monica.



  • Education & Training

    dept_icon

    Saint Louis University School of Medicine

    Medical School

    dept_icon

    University of Southern California - LAC+USC Medical Center

    Residency

    dept_icon

    UCLA Medical Center

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Ronald Reagan UCLA Medical Center

    Languages: English/Spanish

    (310) 825-9111

    757 Westwood Plaza

    Los Angeles, California 90095

    Read More

    UCLA Medical Center, Santa Monica

    Languages: English/Spanish

    (424) 259-6000

    1250 16th St

    Santa Monica, California 90404

    Read More
  • Publications & Memberships

    Dr. Saeed Sadeghi has contributed to 3 publications.

    Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor recep

    Eiermann W Pienkowski T Crown J Sadeghi S Martin M Chan A Saleh M Sehdev S Provencher L Semiglazov V Press M Sauter G Lindsay MA Riva A Buyse M Drevot P Taupin H Macke...; J Clin Oncol. 2011 Oct 10 .

    See more >>

    Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.

    Johnston S Pippen J Jr Pivot X Lichinitser M Sadeghi S Dieras V Gomez HL Romieu G Manikhas A Kennedy MJ Press MF Maltzman J Florance A O'Rourke L Oliva C Stein S Pegram M; J Clin Oncol. 2009 Nov 20

    See more >>

    Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection.

    Levine AM Sadeghi S Espina B Tulpule A Nathwani B; Cancer. 2002 Mar 1 .

    See more >>